Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Brainstorm Cell Therapeutics Inc.

OTC: BCLI · Life Sciences · 2 alerts · CIK 1137883

Share price
$0.9000Close, Nov 16
Market cap
$9.93M
Shares outstanding
11.03MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Brainstorm Cell Therapeutics Inc. filings on SEC EDGAR ↗

4:45 PM ET 10-Q
Financial Results

Brainstorm Cell Therapeutics Q3 2026 Results: Net Loss of $1.73M, Loss Narrows

BrainStorm Cell Therapeutics reported a net loss of $7.7 million for the nine months ended September 30, 2026, compared to $7.9 million in the prior year period. The company faces a significant stockholders' deficit of $12.3 million and maintains a very low cash position of $163 thousand, relying on private placements and short-term loans to fund operations.

Key figure
Net loss $1.73M
4:28 PM ET 8-K
Financial Results

Brainstorm Cell Therapeutics Financial Results

BrainStorm Cell Therapeutics reported financial results for the third quarter ended September 30, 2026, and provided a corporate update on its Phase 3b ENDURANCE study of NurOwn in ALS. The company highlighted the appointment of former FDA official Professor Peter J. Pitts as Executive Chairman to lead regulatory and capital-markets initiatives. Net loss for the quarter was $2.1 million, or $0.03 per share, as the company prepares for the initiation of its next clinical trial phase.

Term
Q3 2026

“ALS remains a devastating disease with a critical unmet medical need, and patients urgently need new therapeutic options. We continue to advance and complete the preparations necessary to initiate the Phase 3b ENDURANCE study of NurOwn® in ALS, supported by an FDA-agreed protocol under a Special Protocol Assessment.”

Chaim Lebovits, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.